Several studies have shown that the MSI-H sporadic GC is mainly due to the inactivation of hMLH1 by the epigenetic silencing of the gene [85,89,90], while most tumors with a loss of hMSH2 expression have germline hMSH2 mutations [60,91]. This evidence concerns the gene MSH2 and gastric cancer.